In pancreatic cancer, the molecular mechanisms of cigarette smoking are currently unknown; however, a synergic role of nicotine metabolites and rare mutations (i.e., KRAS mutations) has been proposed. This evidence concerns the gene KRAS and familial pancreatic carcinoma.